5 New Stock Picks of Billionaire Ken Fisher

2. Blueprint Medicines Corporation (NASDAQ:BPMC)

Number of Hedge Fund Holders: 36  

Blueprint Medicines Corporation (NASDAQ:BPMC) is a Cambridge-based precision therapy company. In July, the company had obtained regulatory approval for AYVAKIT, a drug developed for the treatment of a rare hematologic disorder. The company has a market cap of $6.7 billion and posted close to $800 million in revenue last year. 

Fisher Asset Management owned 315,658 shares in Blueprint Medicines Corporation (NASDAQ:BPMC) at the end of September 2021 worth $32.4 million, representing 0.02% of the portfolio. 

At the end of the second quarter of 2021, 36 hedge funds in the database of Insider Monkey held stakes worth $848 million in Blueprint Medicines Corporation (NASDAQ:BPMC), up from 31 in the preceding quarter worth $1 billion.